These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1831533

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Multidisciplinary therapy using interferon and immunological evaluation for glioma patients: two-color analysis of T cell subsets].
    Numa Y, Kawamoto K, Matsumura H.
    No Shinkei Geka; 1991 Feb; 19(2):121-8. PubMed ID: 1708857
    [Abstract] [Full Text] [Related]

  • 6. [Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors].
    Akimoto M, Nishihira T, Hirakawa H, Abe M, Ohuchi N, Mori S, Kumagai K.
    Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):64-74. PubMed ID: 2014029
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):799-811. PubMed ID: 2196311
    [Abstract] [Full Text] [Related]

  • 11. [Intratumoral injection of OK-432 in conjunction with fibrinogen greatly enhances antitumor effect on colorectal carcinomas].
    Monden T, Morimoto H, Murotani M, Yagyu T, Nagaoka H, Shimano T, Mori T.
    Nihon Geka Gakkai Zasshi; 1991 Jan 20; 92(1):31-6. PubMed ID: 1707498
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H, Reynolds CW.
    J Natl Cancer Inst; 1987 Nov 20; 79(5):1019-24. PubMed ID: 3500354
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of intratumoral administration of OK-432 on breast cancer--analysis of T cell subsets of tumor infiltrating lymphocytes by using the immunohistological stainings--preliminary report].
    Hosokawa T, Haga S, Shimizu T, Iida T, Imamura H, Watanabe O, Kajiwara T.
    Nihon Geka Gakkai Zasshi; 1989 Feb 20; 90(2):316. PubMed ID: 2787471
    [No Abstract] [Full Text] [Related]

  • 15. Effect of OK-432 on cytotoxic activity in cancer patients without tumor burden.
    Fujieda S, Saito H, Isobe Y, Nakagawara G, Nishi O, Nagahara K, Watanabe Y, Hoshino T.
    Anticancer Res; 1992 Feb 20; 12(6B):1941-5. PubMed ID: 1341892
    [Abstract] [Full Text] [Related]

  • 16. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM, Golub SH.
    Nat Immun Cell Growth Regul; 1992 Feb 20; 3(4):193-202. PubMed ID: 6241293
    [Abstract] [Full Text] [Related]

  • 17. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):997-1012. PubMed ID: 2202770
    [Abstract] [Full Text] [Related]

  • 18. [Intratumoral administration of OK432 in rats with liver tumor].
    Ishimaru M.
    Nihon Geka Gakkai Zasshi; 1988 Jun 20; 89(6):880-8. PubMed ID: 2972906
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.